Customize your JAMA Network experience by selecting one or more topics from the list below.
Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In the article titled “Comparative Safety of Testosterone Dosage Forms,” published online May 11, 2015, and also in this issue of JAMA Internal Medicine (doi:10.1001/jamainternmed.2015.1573), incorrect information appeared in the Abstract. In the Design, Setting, and Participants portion, the second sentence, which read “Participants included 13 men (aged ≥18 years) who initiated use of testosterone patches, gels, or 14 injections following 180 days with no testosterone use.” should be replaced with the following: “Participants included men (aged ≥18 years) who initiated use of testosterone patches, gels, or injections following 180 days with no testosterone use.” This article was corrected online and in print.
Incorrect Numbers in Abstract. JAMA Intern Med. 2015;175(7):1248. doi:10.1001/jamainternmed.2015.3083